4
Changes in Ownership
Calidi Biotherapeutics, Inc. Filed Acc 0001641172-25-026780
Options or other derivatives
- Chief Scientific Officer acquired 35,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Fernandez Santidrian Antonio Chief Scientific Officer | 2025-09-03 | Grant or award · Stock Options (right to buy) | +35,000 | 35,000 | D | ||
Loading xslF345X05/ownership.xml…